Nifty

:

11752.80

Sensex

:

39140.28

-34.35 (-0.29%)
-135.36 (-0.34%)

Login

Nifty
Sensex

:
:

11752.80
39140.28

-34.35 (-0.29%)
-135.36 (-0.34%)

Concord Drugs Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 538965 | NSE: Not Listed

Watchlist

NSE BSE

22.90

1.05 (4.81%)

18-Apr-2019 | 4:01PM

Day's Open
Day's High
Day's Low
Previous Close

21.60
22.90
21.60
21.85

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1229
0.28
33.65
15.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17.18
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

30.75
N/A
0.84

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
8.82
0.73

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
7.14
-11.16

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-1.21
-43.24

P:E (Median)

8 Years
5 Years
3 Years

-
-
12.32

P:BV (Average)

8 Years
5 Years
3 Years

-
-
1.71

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
8.76

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 18 Dec 17 Var% Sep 18 Sep 17 Var% Jun 18 Jun 17 Var% Mar 18 Mar 17 Var%
Net Sales 9.21 5.96 54.53% 11.49 3.77 204.77% 13.03 20.97 -37.86% 21.10 21.43 -1.54%
Expenses 8.22 4.43 85.55% 10.52 2.81 274.38% 12.03 19.80 -39.24% 21.34 22.17 -3.74%
EBITDA 0.98 1.53 -35.95% 0.97 0.96 1.04% 1.00 1.17 -14.53% -0.25 -0.74 -
EBIDTM 10.69% 25.62% 8.42% 25.40% 7.69% 5.59% -1.18% -3.46%
Other Income 0.02 0.01 100.00% 0.02 0.00 0.00 0.03 0.01 200.00% 0.18 0.03 500.00%
Interest 0.40 0.43 -6.98% 0.39 0.30 30.00% 0.42 0.58 -27.59% 0.64 0.71 -9.86%
Depreciation 0.55 0.60 -8.33% 0.55 0.57 -3.51% 0.54 0.55 -1.82% 0.68 0.72 -5.56%
PBT 0.06 0.51 -88.24% 0.05 0.08 -37.50% 0.07 0.05 40.00% -1.39 -2.14 -
Tax 0.02 0.15 -86.67% 0.01 0.03 -66.67% -0.06 0.06 - -0.06 -0.37 -
PAT 0.04 0.36 -88.89% 0.04 0.06 -33.33% 0.13 -0.01 - -1.33 -1.78 -
PATM 0.40% 5.97% 0.32% 1.57% 0.98% -0.05% -6.29% -8.29%
EPS 0.05 0.45 -88.89% 0.05 0.08 -37.50% 0.16 -0.01 - -1.69 -2.45 -

Description Dec 18 Dec 17 Var% Sep 18 Sep 17 Var% Jun 18 Jun 17 Var% Mar 18 Mar 17 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 54.83 51.80 57.49 50.68 40.02 33.95 28.07 27.67 24.13 Net Sales Growth 5.18% -9.90% 13.44% 26.64% 17.88% 20.95% 1.45% 14.67% Cost Of Goods Sold 47.55 34.02 37.24 23.80 25.38 24.16 21.64 22.86 19.10 Gross Profit 7.28 17.78 20.26 26.88 14.64 9.79 6.42 4.81 5.03 GP Margin 13.28% 34.32% 35.24% 53.04% 36.58% 28.84% 22.87% 17.38% 20.85% Total Expenditure 52.11 47.24 51.98 42.44 33.00 30.72 25.75 24.52 21.49 Power & Fuel Cost - 0.70 0.97 0.77 0.34 0.50 0.23 0.23 0.37 % Of Sales - 1.35% 1.69% 1.52% 0.85% 1.47% 0.82% 0.83% 1.53% Employee Cost - 1.73 2.57 1.61 0.44 0.29 0.14 0.05 0.23 % Of Sales - 3.34% 4.47% 3.18% 1.10% 0.85% 0.50% 0.18% 0.95% Manufacturing Exp. - 9.46 9.34 15.68 6.30 4.84 2.81 0.12 0.88 % Of Sales - 18.26% 16.25% 30.94% 15.74% 14.26% 10.01% 0.43% 3.65% General & Admin Exp. - 1.09 1.57 0.48 0.47 0.75 0.75 0.49 0.50 % Of Sales - 2.10% 2.73% 0.95% 1.17% 2.21% 2.67% 1.77% 2.07% Selling & Distn. Exp. - 0.16 0.27 0.05 0.05 0.18 0.15 0.21 0.38 % Of Sales - 0.31% 0.47% 0.10% 0.12% 0.53% 0.53% 0.76% 1.57% Miscellaneous Exp. - 0.08 0.03 0.06 0.02 0.00 0.03 0.56 0.04 % Of Sales - 0.15% 0.05% 0.12% 0.05% 0% 0.11% 2.02% 0.17% EBITDA 2.70 4.56 5.51 8.24 7.02 3.23 2.32 3.15 2.64 EBITDA Margin 4.92% 8.80% 9.58% 16.26% 17.54% 9.51% 8.27% 11.38% 10.94% Other Income 0.25 0.37 0.15 0.20 0.37 0.12 0.00 0.03 0.10 Interest 1.85 1.88 2.42 2.57 2.72 1.78 0.52 0.39 0.18 Depreciation 2.32 2.40 2.58 2.91 3.63 1.14 0.72 0.60 0.43 PBT -1.21 0.64 0.65 2.96 1.05 0.43 1.08 2.19 2.13 Tax -0.09 0.31 0.49 1.21 0.35 0.09 0.04 0.59 0.50 Tax Rate 7.44% 48.44% 75.38% 40.88% 33.33% 20.93% 3.70% 26.94% 23.47% PAT -1.12 0.32 0.16 1.75 0.70 0.34 1.04 1.59 1.63 PAT before Minority Interest -1.12 0.32 0.16 1.75 0.70 0.34 1.04 1.59 1.63 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -2.04% 0.62% 0.28% 3.45% 1.75% 1.00% 3.71% 5.75% 6.76% PAT Growth 0.00% 100.00% -90.86% 150.00% 105.88% -67.31% -34.59% -2.45% Unadjusted EPS -1.43 0.41 0.22 2.41 0.96 0.47 1.44 2.20 3.00

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 19.32 18.99 15.07 13.32 14.57 14.24 12.81 10.47 Share Capital 7.86 7.24 7.24 7.24 7.24 7.24 7.24 5.61 Total Reserves 11.46 11.75 7.82 6.07 5.38 5.04 4.00 2.08 Non-Current Liabilities 6.38 7.23 16.65 12.77 12.06 11.64 4.95 1.79 Secured Loans 2.48 2.48 6.80 9.70 11.14 10.56 5.04 2.04 Unsecured Loans 0.92 3.69 5.41 2.93 0.54 0.78 0.00 0.00 Long Term Provisions 2.14 0.09 4.26 0.00 0.00 0.00 0.00 0.00 Current Liabilities 80.71 29.31 20.78 28.12 18.05 15.25 12.15 2.37 Trade Payables 66.37 16.36 9.82 17.76 10.60 9.33 7.78 1.33 Other Current Liabilities 4.96 3.29 1.28 1.00 1.13 0.99 1.00 0.06 Short Term Borrowings 9.01 9.26 7.78 8.64 5.63 4.36 2.94 0.55 Short Term Provisions 0.38 0.39 1.90 0.73 0.69 0.58 0.44 0.42 Total Liabilities 106.41 55.53 52.50 54.21 44.68 41.13 29.91 14.63 Net Block 13.51 13.64 15.18 18.32 20.84 5.48 4.79 3.53 Gross Block 30.79 28.52 27.47 28.16 27.06 10.56 9.15 7.29 Accumulated Depreciation 17.28 14.88 12.30 9.85 6.22 5.08 4.36 3.76 Non Current Assets 64.22 25.36 15.97 18.58 21.37 20.38 11.47 6.87 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 13.84 3.37 2.79 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 50.71 11.72 0.79 0.27 0.53 1.06 3.29 0.50 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.05 Current Assets 42.20 30.17 36.53 35.63 23.32 20.75 18.43 7.75 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 18.62 11.03 8.15 5.63 4.92 3.57 2.71 1.50 Sundry Debtors 21.35 15.65 25.48 27.40 16.82 15.77 14.53 5.70 Cash & Bank 0.06 0.23 0.04 0.05 0.11 0.13 0.97 0.49 Other Current Assets 2.17 2.03 1.00 0.93 1.47 1.28 0.22 0.07 Short Term Loans & Adv. 1.89 1.22 1.87 1.62 0.92 0.88 0.17 0.07 Net Current Assets -38.51 0.86 15.75 7.51 5.27 5.50 6.28 5.38 Total Assets 106.42 55.53 52.50 54.21 44.69 41.13 29.90 14.62

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 6.88 1.70 3.61 1.75 2.28 1.18 -3.21 0.01 PBT 0.64 0.65 2.96 1.05 0.43 1.08 2.19 2.13 Adjustment 4.19 2.58 5.49 6.34 2.92 1.26 0.63 0.45 Changes in Working Capital 2.42 -1.13 -3.66 -5.04 -1.07 -0.91 -5.60 -2.53 Cash after chg. in Working capital 7.26 2.10 4.79 2.35 2.28 1.43 -2.79 0.05 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.38 -0.39 -1.17 -0.60 0.00 -0.25 -0.42 -0.03 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2.21 -1.04 0.23 -1.10 -2.14 -9.65 -2.44 -3.28 Net Fixed Assets -2.27 -1.05 0.69 -1.10 -2.66 -11.88 -2.44 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.06 0.01 -0.46 0.00 0.52 2.23 0.00 Cash from Financing Activity -4.80 -3.94 -3.86 -0.70 -0.18 7.62 6.14 3.43 Net Cash Inflow / Outflow -0.13 -3.28 -0.01 -0.06 -0.03 -0.84 0.49 0.17 Opening Cash & Equivalents 0.17 -0.09 0.05 0.11 0.13 0.97 0.49 0.32 Closing Cash & Equivalent 0.04 -3.37 0.04 0.05 0.11 0.13 0.97 0.49

Financial Ratios

Standalone

Right to Left

Description Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 24.58 26.22 20.80 18.38 17.42 16.96 15.52 13.70 ROA 0.40% 0.30% 3.28% 1.41% 0.79% 2.93% 7.16% 11.14% ROE 1.69% 0.94% 12.32% 5.37% 2.72% 8.85% 16.85% 21.20% ROCE 7.49% 8.84% 15.90% 11.33% 7.15% 6.30% 15.24% 17.67% Fixed Asset Turnover 1.75 2.05 1.82 1.45 1.80 2.85 3.37 3.31 Receivable days 130.39 130.58 190.42 201.64 175.19 197.02 133.41 86.17 Inventory Days 104.45 60.87 49.61 48.11 45.65 40.81 27.74 22.67 Payable days 283.04 89.32 112.00 142.27 116.02 120.82 68.50 22.43 Cash Conversion Cycle -48.20 102.14 128.03 107.49 104.82 117.01 92.65 86.41 Total Debt/Equity 0.71 0.81 1.33 1.60 1.37 1.28 0.71 0.34 Interest Cover 1.34 1.27 2.15 1.39 1.24 3.10 6.54 12.98

Top Investors:

SAI SARANYA REDDY SEELAM

RAJENDER KUMAR AGARWAL

SUSHIL KUMAR AGARWAL

SANIVARAPU JHANSI

S N THULASI DEVI

EKTA VIJAYWARGI

MOHAN THODUPUNURI

KEDARNATH SRIDHARA

S RAMAKRISHNA REDDY

Annual Reports:

Financial Year 2018

Financial Year 2017

Financial Year 2016

News Update:

Concord Drugs Ltd. - Quarterly Results
14th Feb 2019, 18:20 PM

Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback